Development of a Sustainable Drug-Delivery System Using Biodegradable Polymers for Targeted Cancer Therapy

Project Abstract

A sustainable drug-delivery system employing biodegradable polymers is developed to achieve targeted cancer therapy with enhanced efficacy, reduced systemic toxicity, and improved patient compliance. The study addresses the urgent need for precision medicine by engineering polymeric carriers that respond to tumor-specific microenvironments, enabling on-demand release of chemotherapeutics while preserving healthy tissue integrity. A comprehensive materials design framework was established, incorporating biocompatible polymers such as poly(lactic-co-glycolic acid) (PLGA), poly(caprolactone) (PCL), and naturally derived polymers, conjugated with targeting ligands (e.g., folate, transferrin) and stimuli-responsive linkers that react to acidic pH, elevated glutathione levels, or enzymatic activity characteristic of tumor tissues. Advanced fabrication techniques, including nanoprecipitation, emulsion-solvent evaporation, and microfluidic-assisted synthesis, were optimized to produce uniform nanoparticles and hydrogel systems with tunable size, surface charge, drug loading, and release profiles. In vitro studies demonstrated enhanced selective uptake by cancer cell lines overexpressing target receptors, facilitated by receptor-mediated endocytosis, and a significant reduction in off-target cytotoxicity compared with conventional formulations. Release kinetics were governed by multi-stimuli triggers, enabling a rapid burst in acidic intracellular compartments followed by sustained diffusion-controlled release, thereby maintaining therapeutic drug concentrations within the tumor microenvironment over extended periods. The system also incorporated biodegradable linkages to ensure complete polymer degradation within physiological timelines, mitigating long-term accumulation and associated risks. In vivo evaluation using murine tumor models highlighted superior antitumor efficacy, achieved through heightened intratumoral drug concentration and improved biodistribution with minimized systemic exposure. Pharmacokinetic analyses indicated prolonged circulation half-lives and a favorable area under the curve, correlating with enhanced tumor suppression and reduced hematological toxicity. Immunohistochemical assessments revealed induction of apoptosis and suppression of proliferation indices within tumor tissues, while histopathology confirmed negligible damage to major organs, underscoring the biocompatibility and safety of the delivery platform. Additionally, the research explored the environmental sustainability of the production process by employing green solvent systems, solvent-recycling protocols, and scalable manufacturing routes to reduce ecological impact and facilitate translation to clinical manufacturing. A techno-economic assessment projected cost-effectiveness relative to standard chemotherapy regimens, factoring in reduced dosing frequency, decreased hospitalization due to adverse events, and potential improvements in patient quality of life. The study identifies critical challenges, including long-term immunogenicity, regulatory hurdles for combination therapies, and the need for robust storage stability. Future work proposes integration with diagnostic imaging agents for theranostic applications, exploration of patient-specific dosing regimens through pharmacogenomic data, and expansion to other cancer subtypes. Overall, the developed sustainable biodegradable polymer-based delivery system represents a versatile and clinically translatable approach to achieving targeted, efficient, and environmentally responsible cancer therapy.

Project Overview

What This Project Is About

---

A straightforward look at how biodegradable polymers can be used to deliver cancer drugs directly to tumors, reducing side effects and improving effectiveness. The project compares different biodegradable materials, how they release drugs over time, and how targeting methods can steer the medicine to cancer cells.

---

---

The Problem It Addresses

---

Chemotherapy often harms healthy tissue because drugs travel through the body. Conventional formulations can cause severe side effects and require high doses. This project aims to create safe, patient-friendly delivery systems that release drugs where they are needed and degrade afterward without leaving harmful residues.

---

---

Objectives of the Project

---

1. Understand how biodegradable polymers work for drug delivery.
2. Identify polymers that safely release cancer drugs over a chosen time.
3. Explore targeting strategies to reach tumor sites more precisely.
4. Evaluate basic safety and degradation profiles in simple models.
5. Develop a simple prototype formulation for a chosen drug.

---

---

What You Will Do Step by Step

---

1) Review basic literature on biodegradable polymers and drug delivery concepts. 2) Select candidate polymers and a model anticancer drug. 3) Formulate delivery systems (e.g., capsules or nanoparticles) using simple lab techniques. 4) Test how quickly and where the drug is released under simulated conditions. 5) Consider targeting approaches (surface modifications, responsiveness). 6) Assess safety indicators in basic tests and discuss possible improvements. 7) Compile results into a clear report with figures and a simple cost/materials assessment.

---

---

---

---

Expected Outcome

A simple, well-documented strategy for a biodegradable drug-delivery system that shows controlled release and basic targeting prospects, with clear notes on potential benefits for patient safety and treatment effectiveness.